Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry
CHAPEL HILL, N.C., Sept. 4, 2015 /PRNewswire/ -- Physician E-sampling is becoming well established across many companies and therapeutic areas, and has become a key marketing sales tactic in recent years. However, some organizations are still slow to fully adopt E-sampling as a supplement to traditional sampling.
According to research by benchmarking firm, Best Practices, LLC, physician E-sampling has been seeded across multiple therapeutic areas- including diabetes and most other large chronic areas. While E-sampling has been in place for five or more years at many companies, 1/4 of the benchmark class is still new to the channel. Physician E-sampling innovation seems to be stimulated simultaneously by difficulty reaching physicians, sales resource limitations and evolving specialty models.
The related report, "Current and Future Trends in Physician E-Sampling: Managing for Superior Sales, Access, Service & Cost Benefits," identifies and documents current practices and trends in physician E-sampling across the biopharmaceutical industry.
Key study objectives were:
- Benchmarking how pharmaceutical companies organize their efforts in E-sampling
- Identifying common organizational structures, budgets, and performance measurement processes
- Gaining insights into trends, challenges, and lessons learned in this tactic
This report will help organizations to improve the efficiency and effectiveness of their E-sampling programs through the benchmarks provided by 31 leaders at 22 organizations, including nine Top 25 pharma companies.
To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1160.htm
For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.